市場調查報告書
商品編碼
707339

全球心血管超音波設備市場:各檢驗類型、技術、設備顯示器、終端用戶、地區 - 成長率,市場趨勢,市場預測(2018年∼2023年)

Cardiovascular Ultrasound System Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球心血管超音波設備市場,預計從2018年到2023年以5.6%的年複合成長率發展。近幾年的技術進步和心血管手術實施數量的增加成為這個市場的主要成長要素。

本報告提供全球心血管超音波設備市場調查,市場概要,各檢驗類型、技術、設備顯示器、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 成長要素,阻礙因素,市場機會,課題(DROC)

  • 市場成長要素
    • 心臟血管疾病(CVD)的罹患率的上升
    • 技術的進步
    • 與侵入性治療比較時,心臟超音波圖檢驗的優點
  • 市場阻礙因素
    • 不利的償付方案
    • 新技術引進的經濟影響
  • 市場機會
  • 主要課題

第7章 心血管超音波設備市場:各市場區隔

  • 各檢驗類型
    • 胸前心臟超音波圖檢驗
    • 經食道心臟超音波圖檢驗
    • 運動負擔心臟超音波圖檢驗
    • 其他
  • 各技術
    • 2D
    • 3D、4D
    • 多普勒成像
  • 各設備顯示器
    • 彩色表示
    • 黑白表示
  • 各終端用戶
    • 醫院、心臟病中心
    • 門診病人治療、家庭治療
    • 醫療設備廠商、製藥企業
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 企業簡介和競爭情形

  • Canon Medical Systems
  • Chison
  • Esaote SpA
  • GE Healthcare
  • 日立Medical
  • KPI Healthcare Inc.
  • Philips Healthcare
  • Siemens Healthcare
  • Samsung Electronics Co., Ltd
  • Whale Imaging

第9章 市場未來展望

目錄
Product Code: 62805

The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period.

The COVID-19 has a profound impact on the cardiovascular imaging system in 2020. The factor negatively impacting the studied market is the reduction in the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID-19 patients.

However, patients with underlying heart disease are at higher risk of severe illness for COVID-19. In Such Patients, diagnostic ultrasound can and is being used to diagnose COVID-19 in patients. Ultrasound of the heart, which can be performed at the bedside, has become a key tool for clinicians while treating and monitoring COVID-19 patients. The risk of contamination and nosocomial spreading associated with the usage of the standard diagnostic tools such as stethoscope and radiology imaging systems in the management of COVID -19 contributed to the rising demand for pocket-sized cardiovascular ultrasound systems changing the dynamics of these market spaces.

The major factors for the growth of the cardiovascular ultrasound system market include - the increasing incidence of cardiovascular diseases (CVDs), rise in technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures.

Cardiovascular diseases (CVD) remain a substantial cause of morbidity and mortality in the developed world and are becoming an increasingly important cause of death in developing countries. As per the 2020 updates of the World Health Organization, ischemic heart disease, responsible for 16% of the world's total deaths. Since 2000, the largest increase in deaths has been for ischemic heart disease, rising by more than 2 million to 8.9 million deaths in 2019. Consequently, the increase in the number of cardiovascular diseases has increased the demand for the cardiovascular ultrasound system for diagnosis.

Technological advancement such as artificial intelligence has a significant positive impact on cardiology with improved capabilities to diagnose certain heart conditions. For instance, in October 2020, GE Healthcare received the US FDA 510k clearance for its ultra edition package of vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

However, factors, like unfavorable reimbursement scenarios and the economic impact of adopting new technologies, are likely to impede the studied market growth over the forecast period.

Key Market Trends

The 2D Ultrasound Imaging Segment is Expected to be Fastest Growing Segment Over the Forecast Period

The COVID-19 impacted the production of 2D cardiovascular ultrasound systems in 2020. Furthermore, the delay of elective procedures due to COVID-19-related measures adversely affected the cardiovascular medical devices market, especially in the year 2020. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. Hence, lifestyle changes and medication can be temporarily prescribed instead of cardiovascular procedures for some patients. Another factor negatively impacting the verticle is the reduction in the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID-19 patients.

2D ultrasound imaging is also known as B-mode echography or sonography. It displays a 2D map of B-mode data and is currently the most common form of cardiac ultrasound imaging used worldwide. It uses multiple transducers. It enables the generation of multiple images of the field or frames every second on the screen, giving an illusion of movement. It is primarily used to measure cardiac chamber dimensions, assess valvular structure and function, and improve the accuracy of interpretation of Doppler modalities.

2D ultrasound is one of the most common forms of technology used. However, it has disadvantages, like low resolution, distortion of ultrasound wave resulting in inaccurate images, view of the internal bone structure, and regional placement.

Moreover, technological advancements, like Doppler imaging and 3D/4D ultrasound imaging, are expected to affect the global 2D imaging market during the forecast period. For instance, in October 2020, Royal Philips launched the Ultrasound 3300, a new innovative ultrasound series tailored for general Imaging and cardiovascular imaging procedures. Such product advancement will boost vertical growth over the coming years.

North America is Expected to Dominate the Market Over the Forecast Period

North America is anticipated to lead the market owing to the high adoption of ultrasound modality in general diagnostics and the rising prevalence of lifestyle-associated chronic diseases. The high demand for technologically advanced medical devices is expected to propel market growth in the region.

According to the American Heart Association Research Report 2018, Heart disease accounts for 1 in 7 deaths in the United States. Coronary Heart Disease is the leading cause (43.8%) of deaths attributable to cardiovascular disease in the United States, followed by stroke (16.8%), heart failure (9.0%), high blood pressure (9.4%), diseases of the arteries (3.1%), and other cardiovascular diseases (17.9%). aThis scenario leads to a higher demand for cardiovascular ultrasound systems for better diagnosis, which will drive the market in the United States.

Furthermore, supportive awareness initiatives for disease awareness are projected to support the market for cardiovascular devices in North America. For instance, in 2020, Mexico joined the HEARTS initiative to strengthen primary healthcare for CVD. Promoted by the Pan American Health Organization/ World Health Organization (PAHO/WHO), the initiative aims to improve the prevention and control of hypertension at the primary care level.

Competitive Landscape

The market studied is moderately consolidated, owing to the presence of many small and large market players. Some market players are Canon Medical Systems, Chison, Esaote SpA, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips NV, KPI Healthcare Inc., Samsung Healthcare, Siemens Healthcare, and Whale Imaging. Regional and service portfolio expansions and mergers and acquisitions are key strategic undertakings adopted by these players.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Cardiovascular Diseases (CVDs)
    • 4.2.2 Rise in Technological Advancements
    • 4.2.3 Advantages of Echocardiography over Invasive Cardiac Diagnostic Procedures
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Reimbursement Scenario
    • 4.3.2 Economic Impact of Adopting New Technologies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Test Type
    • 5.1.1 Transthoracic Echocardiogram
    • 5.1.2 Transesophageal Echocardiogram
    • 5.1.3 Stress Echocardiogram
    • 5.1.4 Other Test Types
  • 5.2 By Technology
    • 5.2.1 2D
    • 5.2.2 3D and 4D
    • 5.2.3 Doppler Imaging
  • 5.3 By Device Display
    • 5.3.1 Color Display
    • 5.3.2 Black and White (B/W) Display
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Centers
    • 5.4.3 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems
    • 6.1.2 Chison
    • 6.1.3 Clarius Mobile Health
    • 6.1.4 Esaote SpA
    • 6.1.5 GE Healthcare
    • 6.1.6 Hitachi Medical Corporation
    • 6.1.7 Kalamed Medical System
    • 6.1.8 Koninklijke Philips NV
    • 6.1.9 KPI Healthcare Inc.
    • 6.1.10 Medisono LLC
    • 6.1.11 Samsung Healthcare
    • 6.1.12 Shenzhen Biocare Bio-Medical Equipment Co. Ltd
    • 6.1.13 Siemens Healthcare GmbH
    • 6.1.14 Whale Imaging

7 MARKET OPPORTUNITIES AND FUTURE TRENDS